# Bioqual, Inc.

Canonical: https://abierto.us/vendors/bioqual-inc-ck9lgq7ebnn8

- UEI: CK9LGQ7EBNN8
- CAGE: 059B4
- Location: Rockville, MD
- Awards in window: 13 (27 transactions), $14,653,043 obligated, January 8, 2025 to September 4, 2026

## Awarding agencies

- National Institutes of Health: 13 awards, $14,653,043

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $14,713,084
- 541712 Professional, Scientific, and Technical Services: $1,190
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0
- 541711 Professional, Scientific, and Technical Services: -$25,489
- 541990 All Other Professional, Scientific, and Technical Services: -$35,743

## Competition

- Full and Open Competition: 12 awards
- Not Competed Under SAP: 1 awards

## Solicitations won

- EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES (7529), $10,000. https://abierto.us/opportunities/df7df67782e645aa85bd14b7e52fb76e

## Largest awards

- 75N93019C00069 (definitive contract): $14,073,959, National Institutes of Health Niaid. Animal Care and Laboratory Support Services to the Vaccine Research Center. https://www.usaspending.gov/award/CONT_AWD_75N93019C00069_7529_-NONE-_-NONE-/
- 75N93020F00001 (delivery order): $553,608, National Institutes of Health Niaid. Simian Vaccine Evaluation Units (Sveus). https://www.usaspending.gov/award/CONT_AWD_75N93020F00001_7529_75N93020D00006_7529/
- 75N93020F00002 (delivery order): $371,950, National Institutes of Health Niaid. Simian Vaccine Evaluation Units (Sveus). https://www.usaspending.gov/award/CONT_AWD_75N93020F00002_7529_75N93020D00006_7529/
- 75N93025D00031: $10,000, National Institutes of Health Niaid. Evaluation and Testing Services (Ets) for Vaccines and Other Biologics for Infectious Diseases.. https://www.usaspending.gov/award/CONT_IDV_75N93025D00031_7529/
- HHSN27200012 (delivery order): $1,190, National Institutes of Health Niaid. Holding 50 NHPS. https://www.usaspending.gov/award/CONT_AWD_HHSN27200012_7529_HHSN272201300003I_7529/
- 75N93021F00001 (delivery order): $0, National Institutes of Health Niaid. Conduct Study P215. https://www.usaspending.gov/award/CONT_AWD_75N93021F00001_7529_75N93020D00006_7529/
- 75N93022F00001 (delivery order): $0, National Institutes of Health Niaid. Conduct Study P210-A. https://www.usaspending.gov/award/CONT_AWD_75N93022F00001_7529_75N93020D00006_7529/
- 75N93020D00006: $0, National Institutes of Health Niaid. Simian Vaccine Evaluation Units (Sveus). https://www.usaspending.gov/award/CONT_IDV_75N93020D00006_7529/
- 75N93021D00029: $0, National Institutes of Health Niaid. Comprehensive and Rapid Response for Niaid Research Programs. https://www.usaspending.gov/award/CONT_IDV_75N93021D00029_7529/
- 75N93024D00007: $0, National Institutes of Health Niaid. Preclinical Models of Infectious Diseases. https://www.usaspending.gov/award/CONT_IDV_75N93024D00007_7529/
- 75N93018F00003 (delivery order): -$25,489, National Institutes of Health Niaid. To Further Develop and Refine a Neisseria Gonorrhea (Gc) Infection Model Through the Performance of Approved Protocols Designed to Improve GC Infection Modeling in the Pigtailed Macaque (Macaca Nemestrina) for Prevention and Control of This Sexually. https://www.usaspending.gov/award/CONT_AWD_75N93018F00003_7529_HHSN272201700015I_7529/
- 75N91023P00503 (purchase order): -$35,743, NIH NCI. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N91023P00503_7529_-NONE-_-NONE-/
- 75N93022F00002 (delivery order): -$296,432, National Institutes of Health Niaid. Conduct Study P218. https://www.usaspending.gov/award/CONT_AWD_75N93022F00002_7529_75N93020D00006_7529/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/bioqual-inc-ck9lgq7ebnn8.
